Total Payments
$8,645
2024 Payments
$953.54
Companies
22
Transactions
337
Medicare Patients
13,537
Medicare Billing
$566,396
Payment Breakdown by Category
Food & Beverage$8,608 (99.6%)
Education$36.83 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,608 | 333 | 99.6% |
| Education | $36.83 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,142 | 60 | $0 (2024) |
| PFIZER INC. | $1,114 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $839.69 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $750.60 | 31 | $0 (2024) |
| Medtronic, Inc. | $680.42 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $583.66 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $508.65 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $497.56 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $326.01 | 12 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $272.38 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $953.54 | 38 | Abbott Laboratories ($385.32) |
| 2023 | $1,410 | 56 | Abbott Laboratories ($410.60) |
| 2022 | $1,902 | 76 | Abbott Laboratories ($799.17) |
| 2021 | $1,841 | 74 | Medtronic, Inc. ($381.54) |
| 2020 | $489.81 | 26 | PFIZER INC. ($188.78) |
| 2019 | $614.05 | 24 | Amarin Pharma Inc. ($153.83) |
| 2018 | $767.99 | 22 | PFIZER INC. ($226.22) |
| 2017 | $666.61 | 21 | PFIZER INC. ($172.71) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/07/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Vascular | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $142.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/18/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Vascular | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Vascular | ||||||
| 05/09/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Vascular | ||||||
| 05/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Cardiovascular | ||||||
| 04/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.81 | General |
| 03/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,603 | 4,918 | $697,121 | $152,477 |
| 2022 | 27 | 3,467 | 4,510 | $763,267 | $151,008 |
| 2021 | 25 | 3,407 | 4,296 | $735,790 | $150,026 |
| 2020 | 24 | 3,060 | 3,726 | $687,214 | $112,884 |
Total Patients
13,537
Total Services
17,450
Medicare Billing
$566,396
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 353 | 441 | $122,874 | $35,693 | 29.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 502 | 516 | $151,658 | $25,395 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 84 | $32,844 | $10,544 | 32.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,145 | 1,822 | $55,498 | $10,365 | 18.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 159 | 159 | $38,483 | $8,681 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 85 | $40,767 | $8,485 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $30,162 | $6,913 | 22.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 90 | $20,055 | $5,437 | 27.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 124 | 245 | $27,525 | $5,136 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $15,028 | $3,387 | 22.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 12 | 68 | $13,336 | $3,374 | 25.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 63 | 118 | $23,649 | $3,094 | 13.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 70 | 79 | $14,118 | $3,066 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 30 | $9,870 | $2,777 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $10,240 | $2,716 | 26.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 86 | 170 | $16,090 | $2,681 | 16.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 174 | 174 | $13,835 | $2,591 | 18.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 20 | 104 | $10,279 | $1,882 | 18.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 177 | 177 | $9,474 | $1,728 | 18.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 66 | 70 | $6,133 | $1,207 | 19.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 20 | 20 | $5,222 | $1,101 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 109 | 110 | $6,792 | $1,063 | 15.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 49 | 49 | $4,701 | $987.35 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $3,332 | $950.20 | 28.5% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 13 | 14 | $3,562 | $774.41 | 21.7% |
About Dr. Steven Isserman, M.D
Dr. Steven Isserman, M.D is a Cardiovascular Disease healthcare provider based in Morganton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518920271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Isserman, M.D has received a total of $8,645 in payments from pharmaceutical and medical device companies, with $953.54 received in 2024. These payments were reported across 337 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,608).
As a Medicare-enrolled provider, Isserman has provided services to 13,537 Medicare beneficiaries, totaling 17,450 services with total Medicare billing of $566,396. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Morganton, NC
- Active Since 04/11/2006
- Last Updated 03/29/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518920271
Products in Payments
- ELIQUIS (Drug) $1,344
- JOT DX (Device) $833.11
- ENTRESTO (Drug) $502.41
- JARDIANCE (Drug) $490.32
- VERQUVO (Drug) $474.52
- BRILINTA (Drug) $427.47
- FARXIGA (Drug) $384.97
- LINQ II (Device) $371.09
- XARELTO (Drug) $326.01
- CAMZYOS (Drug) $313.33
- LifeVest (Device) $272.38
- LEQVIO (Drug) $248.19
- CONFIRM RX (Device) $230.22
- AVEIR (Device) $195.49
- MICRA (Device) $173.79
- Vascepa (Drug) $153.83
- DRAGONFLY OPSTAR (Device) $134.17
- PRALUENT (Drug) $125.00
- Confirm Rx (Device) $122.93
- WATCHMAN Access System (Device) $119.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Morganton
Sean Pokorney, Md, MD
Cardiovascular Disease — Payments: $410,394
Cardiovascular Disease $410,394
Fernando De La Serna, Md, MD
Cardiovascular Disease — Payments: $6,359
Cardiovascular Disease $6,359
Dr. Walter Pearcy, M.d, M.D
Cardiovascular Disease — Payments: $4,663
Cardiovascular Disease $4,663
Dr. Ryan Miller, M.d, M.D
Cardiovascular Disease — Payments: $1,216
Cardiovascular Disease $1,216
Dr. Sardar Shah Khan, M.d., M.r.c.p, M.D., M.R.C.P
Cardiovascular Disease — Payments: $198.26
Cardiovascular Disease $198.26
Dr. Charles Vasey, M.d, M.D
Cardiovascular Disease — Payments: $43.51
Cardiovascular Disease $43.51